
Shareholding5 Jun 2026, 05:51 pm
Panacea Biotec Promoter Group Acquires 2 Lakh Shares via Gift
AI Summary
Rajesh Jain (HUF), a member of the Promoter's Group of Panacea Biotec Limited, is acquiring 2,00,000 equity shares through an off-market inter-se transfer by way of gift from Dr. Rajesh Jain, a Promoter. This transaction falls under Regulation 10(1)(a)(ii) of SEBI (SAST) Regulations, 2011, exempting it from an open offer. The acquisition is at NIL price. Post-acquisition, Rajesh Jain (HUF)'s shareholding will be 13.48% of the total paid-up share capital.
Key Highlights
- Promoter group entity acquires 2 lakh shares via gift.
- Transaction is an inter-se transfer at NIL price.
- Acquisition exempt from open offer under SEBI (SAST) Regulations.
- Rajesh Jain (HUF) shareholding increases to 13.48%.
Price Impact
More from PANACEABIO